|
Market Closed -
Nasdaq
00:00:00 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 56.69 USD | -4.34% |
|
+1.20% | +16.93% |
| 07-13 | GSK posts encouraging data for bowel cancer treatment Jemperli | AN |
| 06-29 | AnaptysBio, Inc.(NasdaqGS:ANAB) dropped from Russell 3000E Growth Benchmark | CI |
| Market Cap | 1.68B 1.44B 1.34B 1.23B 2.31B 161B 2.36B 15.91B 6.2B 80.49B 6.3B 6.17B 266B | P/E 2026 * |
-229x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.59B 1.36B 1.27B 1.16B 2.18B 152B 2.23B 15.03B 5.86B 76.07B 5.96B 5.83B 252B | EV / Sales 2026 * |
16.8x | EV / Sales 2027 * | 9.04x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: AnaptysBio, Inc.
| 1 day | -4.34% | ||
| 1 week | +1.20% | ||
| Current month | +6.24% | ||
| 1 month | +12.73% | ||
| 3 months | -5.64% | ||
| 6 months | +4.61% | ||
| Current year | +16.93% |
| 1 week | 56.33 |  | 60.31 |
| 1 month | 50.51 | | 60.31 |
| Current year | 42 | | 73.3 |
| 1 year | 17.11 | | 73.3 |
| 3 years | 12.21 | | 73.3 |
| 5 years | 12.21 | | 73.3 |
| 10 years | 10 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 46 | 21/03/2022 |
| Director of Finance/CFO | 42 | 11/05/2026 | |
Benjamin Stone
PRN | Corporate Officer/Principal | 35 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 79 | 30/06/2015 |
John Schmid
BRD | Director/Board Member | 63 | 30/06/2015 |
Oleg Nodelman
BRD | Director/Board Member | 49 | 08/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/02/26 | Fiscal year | Chief Financial Officer | 30,000 | 0.1083% | ||
| 15/01/26 | Fiscal year | Director | 33,000 | 0.1192% | ||
| 07/01/26 | Fiscal year | Chief Executive Officer | 67,957 | 0.2454% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.34% | +1.20% | +181.34% | +189.09% | 1.68B | |
| +2.38% | +3.43% | +82.88% | +115.89% | 73.96B | |
| -0.50% | +20.60% | +52.88% | +93.07% | 64.66B | |
| -4.27% | -0.99% | -3.38% | +475.61% | 27.32B | |
| -1.97% | +20.38% | -0.37% | +0.48% | 27.86B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 25.97B | |
| -0.35% | +5.23% | +35.51% | -14.51% | 19.98B | |
| -1.79% | -4.84% | +239.54% | +414.48% | 17.84B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.24B | |
| -1.29% | +6.09% | +41.81% | +154.45% | 13.3B | |
| Average | -0.85% | +5.69% | +71.16% | +198.96% | 28.88B | |
| Weighted average by Cap. | -0.02% | +8.17% | +59.64% | +160.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 94.28M 80.72M 75.31M 69.11M 130M 9.02B 132M 893M 348M 4.52B 354M 346M 14.97B | 153M 131M 122M 112M 211M 14.66B 215M 1.45B 566M 7.35B 575M 563M 24.32B |
| Net income | -7.47M -6.39M -5.97M -5.47M -10.29M -715M -10.49M -70.77M -27.59M -358M -28.04M -27.43M -1.19B | 129M 110M 103M 94.35M 177M 12.32B 181M 1.22B 476M 6.17B 483M 473M 20.43B |
| Net Debt | -92.22M -78.96M -73.67M -67.6M -127M -8.82B -130M -874M -341M -4.42B -346M -339M -14.64B | -293M -251M -234M -215M -404M -28.04B -412M -2.78B -1.08B -14.05B -1.1B -1.08B -46.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | $56.69 | -4.34% | 389,386 |
| 19/08/26 | $59.26 | +0.46% | 258,753 |
| 18/08/26 | $58.99 | -1.17% | 260,449 |
| 17/08/26 | $59.69 | +2.09% | 255,839 |
| 14/08/26 | $58.47 | +4.37% | 330,885 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANAB Stock
Select your edition
All financial news and data tailored to specific country editions
